Finance News Network interviews CEO Dr Chris Hart on Oventus Canadian sales agreements

Oventus CEO and founder, Dr Chris Hart was recently interviewed by Finance News Network’s Jessica Amir.

Following the release in February 2019 of the O₂Vent^® Optima device in Canada, Oventus has just announced the first sales agreements in Canada for Oventus’ sleep apnoea treatment platform.

These are the first agreements with sleep groups for a new ‘lab in lab’ model, to supply O₂Vent^® Optima devices directly to the sleep facilities for the treatment of their patients.

To hear more on these ‘lab in lab’ agreements and the launch of the ExVent^TM PEEP valve technology, click here to watch the video.

https://www.finnewsnetwork.com.au/archives/finance_news_network233277

https://www.finnewsnetwork.com.au/

Leave a Reply

Click here to cancel reply.

Name (required)

Email (will not be published) (required)

Website

Comment

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>